Project Grant R01AI158314

Award Date 7/15/22
Completion Date 6/30/27
Dollars Obligated $5.2M
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Chapel Hill, NC 27599, USA
Similar Awards
This $209,444 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to understand how SARS-CoV-2 infection promotes harmful inflammatory responses. The primary objectives are to: Determine which specific inflammasome complexes drive detrimental IL-1β release during severe COVID-19 and identify the key tissues involved. Define the mechanisms by which SARS-CoV-2...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $188,544 to study the role of the protein SAMHD1 in regulating inflammation and immune responses during SARS-CoV-2 infection. The research aims to characterize how SARS-CoV-2 infection alters SAMHD1 phosphorylation, and examine the impact on viral replication and innate immunity using in vitro human airway...
This $190,058 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will fund research to define the role of the ADAM9 protein in modulating the innate immune response to SARS-CoV-2 infection and its impact on lung pathology. The research will be conducted at the University of Massachusetts Medical School (UMass Medical) from December 2024 to November 2029. The principal investigator...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a 5-year, $408,606 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Oklahoma State University (OSU) to investigate the role of ERK1/2 signaling in SARS-CoV-2-induced dysregulated immunity and lung pathology. The key objectives of the research project are to: Define the role of myeloid cell-intrinsic TLR-ERK1/2 activity in SARS-CoV-2-induced lung injury and pathology. Demonstrate the role of myeloid...
This $480,990 federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) aims to investigate the role of "aerocytes" - a specialized capillary endothelial cell population - in facilitating alveolar epithelial regeneration following lung injury associated with acute respiratory distress syndrome (ARDS). The research, conducted by the University of Illinois, will focus on understanding how...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $1,340,904 to the University of Virginia to investigate the role of interleukin-13 (IL-13) and hyaluronan (HA) in the pathology of COVID-19. The 4-year project, beginning August 2024, aims to determine how IL-13 induces HA matrices in the lungs during SARS-CoV-2 infection and how this leads to inflammation and respiratory...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $503,637 to The University of Kentucky Research Foundation to conduct research on the mechanisms of thrombosis (blood clotting) in patients with SARS-CoV-2 infection, the virus that causes COVID-19. The research aims to investigate how COVID-19 leads to the formation of microclots, which can cause localized tissue damage, as well as the...
This federal Project Grant award of $463,125.00, funded by the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to study the role of cellular senescence in severe COVID-19 outcomes associated with pre-existing obesity and non-alcoholic steatohepatitis (NASH). The key objectives are to investigate whether genetically or chemically removing senescent cells in mouse models of obesity/NASH and SARS-CoV-2...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $1,241,876 over a period of 5 years to the Regents of the University of Michigan to conduct research on the role of the histone methyltransferase MLL1 in regulating endothelial dysfunction and endotheliitis during SARS-CoV-2 infection. The key objectives are to: 1) Determine the mechanism by which MLL1 targets endothelial cell...
This $693,942 National Institutes of Health National Heart Lung and Blood Institute Project Grant funds research at Northwestern University aimed at elucidating epigenetic modifiers of regulatory T cell function following viral pneumonia. The goal is to establish causal links between DNA methyltransferase activity, the DNMT adapter UHRF1, and DNA hypermethylation signatures in regulatory T cells during aging and their impaired reparative function after severe viral pneumonia. Through three...

ROLE AND MITIGATION OF INFLAMMASOMES AND INFLAMMATION DURING COVID-19 - PROJECT ABSTRACT THE COVID-19 PANDEMIC CAUSED BY SARS-COV-2 HAS RESULTED IN SWIFT AND CATASTROPHIC LOSSES OF HUMAN LIVES GLOBALLY. ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) IS ONE OF THE MOST DETRIMENTAL OUTCOMES OF COVID-19 INFECTION THAT CAN LEAD TO THE RAPID DETERIORATION AND DEATH OF PATIENTS. ARDS IS PRIMARILY CAUSED BY THE CYTOKINE STORM WHICH UNLEASHES A PLETHORA OF INFLAMMATORY CYTOKINES DURING THE LATE STAGES OF COVID-19. THE MASTER CYTOKINES THAT ARE THOUGHT TO BE RESPONSIBLE FOR MUCH OF THE DAMAGE ARE INTERLEUKIN 1 (IL-1), INTERLEUKIN 6 (IL-6) AND TUMOR NECROSIS FACTOR (TNF). CURRENTLY TWO CLINICAL TRIALS HAVE SHOWN THE EFFICACY OF IL-1 INHIBITOR IN COVID- 19 PATIENTS. HOWEVER, IN MANY CASES, THE MECHANISM AND IMPACT OF THESE CYTOKINES DURING SARS-COV-2 INFECTION ARE POORLY UNDERSTOOD. AN IN-DEPTH MECHANISTIC UNDERSTANDING OF CYTOKINE INDUCTION IS IMPORTANT BECAUSE THIS UNDERSTANDING WILL SIGNIFICANTLY IMPACT THE DESIGN AND SUCCESS OF ARDS TREATMENT. THIS APPLICATION FOCUSES ON THE ROLE AND MITIGATION OF THE INFLAMMASOME COMPLEX WHICH LEADS TO THE PROINFLAMMATORY CYTOKINE, IL-1SS, IN ARDS. THE INFLAMMASOME IS A PROTEIN SUPRAMOLECULAR STRUCTURE THAT LEADS TO CASPASE 1 ACTIVATION, WHICH THEN CLEAVES PRO-IL-1SS AND PRO-IL-18 TO MATURE IL-1SS AND IL-18. IN ADDITION TO THE RELEASE OF IL-1SS AND IL- 18, CASPASE 1 CLEAVES GASDERMIN D TO CAUSE INFLAMMATORY PYROPTOTIC CELL DEATH, THUS LEADING TO A CASCADE OF CELL DEATH AND INFLAMMATION. THE INFLAMMASOME IS COMPRISED OF A RECEPTOR OR SENSOR, WITH THE MOST PROMINENT ONES REPRESENTED BY NLRP1, NLRP3, NLRP6, NLRC4 AND AIM2. IT ALSO INCLUDES AN ADAPTOR MOLECULE ASC (APOPTOSIS-ASSOCIATED SPECK-LIKE PROTEIN CONTAINING A CARD), AND THE EFFECTOR CASPASE-1. EACH RECEPTOR OR SENSOR CAN BE ACTIVATED BY SPECIFIC PATHOGEN PRODUCTS CALLED PAMPS OR CELL DAMAGE ASSOCIATED MOLECULES CALLED DAMPS. SINGLE CELL RNASEQ DATA FROM COVID-19 PATIENTS SHOW DRAMATIC INCREASES OF INFLAMMASOME SENSORS IN THE BRONCHIAL ALVEOLAR LAVAGE OF SEVERE COVID-19 PATIENTS. IN ADDITION, WE FIND A BIDIRECTIONAL FEED- FORWARD LOOP OF INFLAMMASOME ACTIVATION AND INFLAMMATORY CYTOKINE INDUCTION INVOLVING MYELOID CELLS AND AIRWAY STROMAL CELLS. THIS PROPOSAL WILL TEST THE HYPOTHESIS THAT THIS TWO WAY AMPLIFICATION LOOP IS IMPORTANT IN COVID- 19.

Posted 7/15/22, 12:00 AM